Pharma and Life Sciences Validated Workflows with AI Agents
Pharma and life sciences teams live in a world of strict process validation, frequent software updates, and SOPs that only a human can execute reliably. Traditional RPA bots built around fragile selectors or xpaths break when a vendor changes a UI field, and developers must rebuild the bot. Meanwhile, SOPs sit on file with no way to turn them into executable automation. The result is a maintenance backlog and processes that remain manual, increasing the risk of compliance gaps and higher operational costs.
Why RPA breaks here
Most legacy RPA tools in life sciences rely on object selectors and xpaths. When a clinical trial management system adds a new dropdown, changes a label, or reorders fields, the bot can no longer find the target and halts. Enterprise studies show that a single RPA bot can require a full rebuild after every major software update, sometimes multiple times per year. Each rebuild needs developer time, testing, and revalidation documentation. In a highly regulated environment, that drag adds up. Meanwhile, SOPs written in plain English never make it into automation because turning them into a flowchart bot is expensive and time-consuming. The end result is a mix of brittle bots and human-only work that is hard to track, hard to audit, and hard to scale.
What changes with computer use agents
- ●Survives UI changes because agents see the screen and act like a human
- ●No brittle selectors or xpaths to maintain
- ●Recovers from exceptions instead of halting and requiring a developer intervention
- ●Follows a SOP written in plain English without needing a flowchart bot
- ●Works on legacy Windows applications, Citrix desktops, and virtualized environments where RPA struggles
- ●Operates across browsers and terminals using the same computer use interface
For a VP of automation in life sciences, the one line to remember is: RPA chooses a brittle mapping; computer use agents choose to see and adapt.
How to move without the risk
A phased approach lets you capture value without overcommitting. Start by identifying one high-pain, SOP-heavy process where RPA has historically struggled: for example, batch entry of lab results, manual copying between systems, or routine compliance checks. Document the current SOP in plain language, then pilot a computer use agent using that SOP as the prompt. Measure outcomes: error rates, execution time, and the number of exceptions that require human review. Once you see clear benefits and faster deployment, expand to related processes. Keep RPA for high-volume, stable backend tasks where it still makes sense. The key is to build a portfolio of validated workflows that are resilient to change and easier to audit.
Pharma and life sciences teams can move from brittle RPA bots and undocumented SOPs to validated, resilient workflows by adopting computer use agents. The Coasty team can show you how agents see the screen, follow written instructions, and adapt to UI changes without rebuilding. Book a demo with the Coasty team at https://cal.com/coasty/15min to discuss how validated workflows fit your environment.